The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 24, 2024

Filed:

Mar. 24, 2022
Applicant:

Minervax Aps, Copenhagen, DK;

Inventor:

Per Bo Pedersen Fischer, Frederiksberg, DK;

Assignee:

MINERVAX APS, Frederiksberg, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/315 (2006.01); A61K 39/00 (2006.01); A61K 39/09 (2006.01);
U.S. Cl.
CPC ...
C07K 14/315 (2013.01); A61K 39/092 (2013.01); A61K 39/00 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/58 (2013.01); A61K 2039/70 (2013.01); C07K 2319/00 (2013.01);
Abstract

The present invention relates to an immunogenic fusion protein comprising a first amino acid sequence having at least 80% sequence identity with the amino acid sequence of the N-terminal region of a first group Bsurface protein, which is fused to a second amino acid sequence having at least 80% sequence identity with the amino acid sequence of the N-terminal region of a second group Bsurface protein. Each of the first and the second group Bsurface protein is selected from the group consisting of Rib protein, Alpprotein, Alpprotein, Alpprotein, Alpprotein and AlpC protein. The immunogenic fusion protein further comprises at least one amino acid sequence having at least 80% sequence identity with the amino acid sequence of the N-terminal region of the group Bsurface protein Alp, Alp, Alpor Alp. The invention further pertains to an isolated nucleotide sequence encoding the immunogenic fusion protein; a vector; a host cell; an immunogenic product, a vaccine; and a method for preventing or treating a group Binfection.


Find Patent Forward Citations

Loading…